Search for: "Novartis Ag"
Results 421 - 440
of 440
Sort by Relevance
|
Sort by Date
26 Oct 2007, 1:00 am
(Korea IP Law Blog), Korean trade mark law governs domain name disputes in Korea (Korea IP Law Blog), SpainLipitor patent upheld in Spain: (IPLaw 360), United Kingdom House of Lords overturns the Court of Appeal in the Yeda Appeal over Erbitux: (IPKat), (Inner Temple), (IP Law360), Novartis AG v IVAX Pharmaceuticals UK Ltd [2007] EWCA Civ 971, Court of Appeal dismisses an appeal against the decision of Mr Justice Pumfrey that Novartis' patent for a pharmaceutical… [read post]
21 Oct 2007, 12:55 pm
One such drug is Zelnorm ® , a drug used in the treatment of Irritable Bowel Syndrom ("IBS") and chronic constipation in individuals under 65 years of age. [read post]
19 Oct 2007, 11:06 am
Martin Kuster, MD MOH, Novartis International AG, Switzerland, presented "Nanoparticles in drug delivery: potential avenues and issues. [read post]
11 Oct 2007, 1:13 pm
"When it comes to children under age two there are no recommended doses on these products so it's not reasonable to claim they are safe and effective when used as directed," said Dr. [read post]
25 Sep 2007, 3:00 pm
Marketed in the U.S. by Novartis AG (NVS), Exjade was approved by the FDA for sale in 1995. [read post]
22 Sep 2007, 5:40 am
The HinduBusinessLine reports: Ranbaxy Laboratories has dropped its patent challenge of Novartis AG's hypertension drug Diovan. [read post]
7 Aug 2007, 1:20 am
Novartis Pharmaceuticals Corp. [read post]
2 Aug 2007, 12:44 pm
The drug company Novartis AG will have to defend itself against sex-discrimination claims brought by a group of female sales employees in a $100 million class-action lawsuit, a federal judge has ruled. [read post]
2 Aug 2007, 4:45 am
Employment Law360 has the scoop (subscription required) on this recently-certified class action:A federal judge in Manhattan has granted class action status to a $200 million gender discrimination lawsuit brought against a subsidiary of Novartis AG by female sales employees. [read post]
7 Jun 2007, 1:17 am
The lawsuit says Christopher Woods sought treatment for the condition, called severe priapism, the day after he bought the nutrition beverage made by the pharmaceutical company Novartis AG at a drugstore and drank it. [read post]
6 Jun 2007, 10:30 am
Okay, maybe Novartis needs to fine-tune the formula a bit. [read post]
30 Apr 2007, 12:28 pm
In August, 2004, it was able to expand its market share when Zelnorn was given the additional indication for short term treatment of chronic constipation in men and women under the age of 65. [read post]
30 Apr 2007, 12:28 pm
In August, 2004, it was able to expand its market share when Zelnorn was given the additional indication for short term treatment of chronic constipation in men and women under the age of 65. [read post]
25 Apr 2007, 8:14 pm
By Jason Derry -- Cytos Biotechnology AG has granted a worldwide, exclusive license to Novartis to develop, manufacture, and commercialize its therapeutic vaccine for nicotine addiction, CYT002-NicQb. [read post]
22 Apr 2007, 9:51 pm
By Donald Zuhn -- Last Thursday, Novartis AG announced that it had signed an exclusive license with Antisoma PLC for the worldwide rights to the cancer therapeutic AS1404. [read post]
30 Mar 2007, 5:36 pm
Article in the Wall Street Journal -- Novartis to Suspend U.S. [read post]
6 Dec 2006, 6:01 am
said a U.S. federal court (D NJ) granted a temporary restraining order [TRO] enjoining all sales of generic oxandrolone tablets by Novartis AG'S Sandoz Pharmaceuticals, and Upsher-Smith Laboratories. [read post]
27 Nov 2006, 2:20 pm
AstraZeneca PLC and Novartis AG this year each committed to spending $100 million on research and development in China. [read post]
22 Sep 2006, 12:17 pm
While the FDA has approved Novartis AG's Omnitrope hormone, there has not been a change in the stance taken by the FDA on generic biotechnology drugs. [read post]
5 Jul 2006, 4:13 pm
Food and Drug Administration said on Monday that product labels for three popular asthma medications have been updated to state that the drugs could increase the chance of severe asthma attacks that could result in death.The warnings, first proposed last November, involve long-acting bronchodilator medicines Advair and Serevent, made by GlaxoSmithKline Plc, and Foradil from Novartis AG.In a public health advisory issued on its Web site, the FDA said the inhaled drugs should only be used… [read post]
